Methotrexate Cuts Systolic BP in Rheumatoid Arthritis
MONDAY, Sept. 15, 2025 -- For patients with rheumatoid arthritis (RA), methotrexate significantly reduces systolic blood pressure (SBP), according to a study published online July 31 in the Annals of Medicine.
Arduino A. Mangoni, M.D., Ph.D., from Flinders University in Australia, and colleagues conducted a controlled comparative study of treatment-naive newly diagnosed RA patients commenced on subcutaneous methotrexate (group 1; 31 patients) or the disease-modifying antirheumatic drug comparator sulfasalazine (group 2; 31 patients). At baseline and after one and six months of treatment, clinic SBP and diastolic BP (DBP) and augmentation index were measured.
The researchers found that after six months, patients in group 1 had significantly lower SBP than those in group 2 (−7.4 mm Hg). No significant between-group differences were seen in DBP, augmentation index, or Disease Activity Score-28 C-reactive protein. During methotrexate treatment, there was a significant effect of single nucleotide polymorphisms rs1801133 (methyl tetrahydrofolate reductase) and rs2231142 (ATP-binding cassette subfamily G member 2) on BP changes.
"This kind of reduction is considered meaningful because even a small drop in blood pressure can lower the risk of serious heart problems like heart attacks and strokes," Mangoni said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Elevated BP at Age 7 Years Linked to Premature CVD Mortality
FRIDAY, Sept. 12, 2025 -- Higher blood pressure (BP) at age 7 years is associated with an increased risk for premature cardiovascular disease (CVD) mortality, according to a study...
Voice-Based AI Enables Collection of BP Measurements at Home
FRIDAY, Sept. 12, 2025 -- Use of voice-based artificial intelligence (AI) enables collection and validation of self-reported blood pressure (BP) measurements at home, improving...
Features of Immunesenescence Present in Early Stages of Rheumatoid Arthritis
THURSDAY, Sept. 11, 2025 -- Some features of immunesenescence are present in the very early stages of rheumatoid arthritis (RA), according to a study published online Sept. 3 in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.